Results 151 to 160 of about 13,217 (287)

Solasodine, a Natural Steroidal Alkaloid, Attenuates RANKL‐Induced Osteoclastogenesis and Bone Resorption: A Study Based on Network Pharmacology and Experimental Validation

Journal of Cellular and Molecular Medicine, Volume 30, Issue 12, June 2026.
ABSTRACT Osteoporosis is characterized by excessive bone resorption driven by aberrant osteoclast activation. Solasodine (SOL), a natural steroidal alkaloid, has undefined roles in bone metabolism. This study investigated SOL's effects on RANKL‐induced osteoclastogenesis and its underlying mechanisms.
Yiwei Jiang, Zhiyu Jin, Xiaoyi Ji, Maihuan Wang, Zhen Cao   +4 more
wiley   +1 more source

Correction to: Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study

Osteoporosis International, 2023
T. Hasegawa, N. Ueda, S. Yamada, S. Kato, E. Iwata, S. Hayashida, Y. Kojima, M. Shinohara, I. Tojo, H. Nakahara, T. Yamaguchi, T. Kirita, H. Kurita, Y. Shibuya, S. Soutome, M. Akashi, Japanese Study Group of Co-operative Dentistry with Medicine   +16 more
semanticscholar   +1 more source

Bisphosphonates and Osteonecrosis of the Jaw

, 2009
Bisphosphonate-related Osteonecrosis of the Jaw (BRONJ) is a condition which, according to the American Association of Oral and Maxillofacial Surgeons (AAOMS), adversely affects between .8-12percent of the population, a small yet significant amount of ...
Leah Katz, Chaya
core  

Treatment protocols for the medication-related osteonecrosis of the jaw [PDF]

, 2017
Povećanjem broja pacijenata koji primaju antiresoptivnu ili antiangiogenu terapiju, doktori dentalne medicine se sve češće susreću s medikamentoznom osteonekrozom čeljusti.
Ivković, Tena
core  

Risk factors for the development of osteonecrosis of the jaw (ONJ) in patients receiving alendronate therapy.

, 2018
Risk factors for the development of osteonecrosis of the jaw (ONJ) in patients receiving alendronate therapy.
Wei-Yih Chiu (734247), Keh-Sung Tsai (195798), Jang-Jaer Lee (513491), Wei-Shiung Yang (28865), Jung-Yien Chien (733549)   +4 more
core   +1 more source

History and Etiology of Jawbones Osteonecrosis

Česká Stomatologie a Praktické Zubní Lékařství, 2009
The author reports the overview of possible etiology of the osteonecrosis of the jaws including the most interesting historical cases of these lesions.
L. Hauer
doaj  

SCD1 Regulates Osteoclast Differentiation by Modulating Arachidonic Acid Metabolism and Mitochondrial Homeostasis

The FASEB Journal, Volume 40, Issue 10, 31 May 2026.
This graphical abstract illustrates that SCD1 inhibition by A939572 or the targeted nanovesicle POCM‐NP@A939572 reprograms arachidonic acid metabolism via the COX1‐HPGDS‐PGD2 axis and impairs mitochondrial homeostasis, thereby suppressing osteoclastogenesis and alleviating bone loss in osteoporosis.
Yihao Zhao, Xiaoan Wei, Haihao Wu, Chengjun Yao, Zeyu Zheng, Weishao Chen, Zhenhua Feng, Bao Huang, Zimin Cai, Qize Xue, Jian Chen, Fengdong Zhao, Junhui Liu   +12 more
wiley   +1 more source

Correction to: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?

Osteoporosis International, 2023
T. Hasegawa, A. Kawakita, N. Ueda, R. Funahara, A. Tachibana, M. Kobayashi, E. Kondou, D. Takeda, Y. Kojima, S. Sato, S. Yanamoto, H. Komatsubara, M. Umeda, T. Kirita, H. Kurita, Y. Shibuya, T. Komori, Japanese Study Group of Co-operative Dentistry with Medicine   +17 more
semanticscholar   +1 more source

Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.

, 2010
PURPOSE: To report a case series of patients with the nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw—a form of jaw osteonecrosis that does not manifest with necrotic bone exposure/ mucosal fenestration.
Aljohani S, Fedele S, Yarom N., Di Fede O, D'Aiuto F, Musciotto A, VESCOVI, Paolo, Porter SR, Broccoletti R, Arduino PG, MANFREDI, Maddalena, Campisi G, Lazarovici TS   +12 more
core   +1 more source

Medication related osteonecrosis of the jaw [PDF]

, 2018
Medikamentozna osteonekroza čeljusti, je bolest, koja nastaje upotrebom dviju vrsta lijekova: antiangiogenih lijekova te antiresorptivnih lijekova.
Reschner, Vlatko
core